ARTICLE | Company News
Crucell, Weizmann Institute of Science deal
August 23, 2010 7:00 AM UTC
The institute's technology transfer arm, Yeda Research and Development Company Ltd., granted Crucell exclusive rights to evaluate the institute's antibodies to treat HBV. Crucell will further develop ...